Why Now April 22, 2026 | 1 min Read

Why Now

People have asked why I chose, now, to found Mnemosyne Biosciences.

The answer is that recent “change” gave me the space to reflect — not just on where genomics and support bioinformatics is going, but on what it’s missing.

Sequencing technologies are advancing quickly.
Long-read genomes are becoming routine and base-modification data more accessible.
Single-cell datasets are growing ever larger.

But again and again, I see the same underlying problem: we are very good at generating data, and much less good at building shared understanding, memory, and method around it.

This starts earlier than we like to admit — in how biology is taught, how teachers are supported, and how computation is introduced.

Mnemosyne exists because I believe the solution is not another pipeline, but a joined-up approach:

  • education that treats bioinformatics seriously
  • systems that make analysis reproducible
  • benchmarking that makes claims defensible

That’s why Paideia sits at the centre of what we do — and why the rest of the platform exists at all.

Losing a role gave me time.
Time gave me clarity.
Clarity turned into Mnemosyne.

Stephen Rudd

Stephen Rudd

Founder of Mnemosyne Biosciences Ltd, working across genomics, bioinformatics, and product management.

Stephen has a PhD in plant …